Tag: performance-tracking
The Scorecard: 1 Month Update: ALAB Sell — Correct so far
Revisiting our Sell call on ALAB: entry $351.31, latest $286.69, -18.4%.
The Scorecard: 2 Month Update: SPHR Sell — Correct so far
Revisiting our Sell call on SPHR: entry $147.34, latest $110.44, -25.0%.
The Scorecard: 1 Month Update: ICHR Sell — Correct so far
Revisiting our Sell call on ICHR: entry $59.42, latest $38.06, -35.9%.
The Scorecard: 3 Month Update: AMKR Sell — Correct so far
Revisiting our Sell call on AMKR: entry $60.60, latest $36.81, -39.3%.
The Scorecard: 3 Month Update: NLST Sell — Incorrect so far
Revisiting our Sell call on NLST: entry $2.44, latest $5.86, +140.2%.
The Scorecard: 2 Month Update: LHX Sell — Correct so far
Revisiting our Sell call on LHX: entry $260.92, latest $253.97, -2.7%.
The Scorecard: 3 Month Update: QUBT Sell — Correct so far
Revisiting our Sell call on QUBT: entry $7.43, latest $6.56, -11.7%.
The Scorecard: 1 Month Update: CHTR Sell — Correct so far
Revisiting our Sell call on CHTR: entry $117.55, latest $108.61, -7.6%.
The Scorecard: 2 Month Update: BA Sell — Correct so far
Revisiting our Sell call on BA: entry $210.46, latest $188.35, -10.5%.
The Scorecard: 3 Month Update: SMR Strong Sell — Correct so far
Revisiting our Strong Sell call on SMR: entry $8.81, latest $5.38, -38.9%.